AR027238A1 - CONDROMODULIN-I-RELATED PEPTIDE - Google Patents

CONDROMODULIN-I-RELATED PEPTIDE

Info

Publication number
AR027238A1
AR027238A1 ARP010100208A ARP010100208A AR027238A1 AR 027238 A1 AR027238 A1 AR 027238A1 AR P010100208 A ARP010100208 A AR P010100208A AR P010100208 A ARP010100208 A AR P010100208A AR 027238 A1 AR027238 A1 AR 027238A1
Authority
AR
Argentina
Prior art keywords
condromodulin
related peptide
polypeptide
refers
proteinmism
Prior art date
Application number
ARP010100208A
Other languages
Spanish (es)
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AR027238A1 publication Critical patent/AR027238A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se refiere a un polinucleotido que codifica un polipéptido que está estructuralmente relacionado con condromodulina-I, como así también a la proteínamisma. También se refiere a vectores, células huésped, anticuerpos y métodos recombinantes para produ cir el polipéptido. Adicionalmente se revela ventajasterapéuticas, de diagnostico y de investigacion para estos y otros productos relacionados.It refers to a polynucleotide that encodes a polypeptide that is structurally related to chondromodulin-I, as well as to proteinmism. It also refers to vectors, host cells, antibodies and recombinant methods to produce the polypeptide. Additionally, therapeutic, diagnostic and research advantages for these and other related products are revealed.

ARP010100208A 2000-01-19 2001-01-18 CONDROMODULIN-I-RELATED PEPTIDE AR027238A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17689800P 2000-01-19 2000-01-19
US72431000A 2000-11-28 2000-11-28

Publications (1)

Publication Number Publication Date
AR027238A1 true AR027238A1 (en) 2003-03-19

Family

ID=26872727

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100208A AR027238A1 (en) 2000-01-19 2001-01-18 CONDROMODULIN-I-RELATED PEPTIDE

Country Status (7)

Country Link
EP (1) EP1261639A2 (en)
JP (1) JP2003520590A (en)
AR (1) AR027238A1 (en)
AU (1) AU3647701A (en)
CA (1) CA2398695A1 (en)
MX (1) MXPA02007119A (en)
WO (1) WO2001053344A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784054B2 (en) 1999-09-29 2006-01-19 Teijin Limited Novel polypeptides and genes encoding the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3585180B2 (en) * 1993-05-11 2004-11-04 三菱化学株式会社 Novel human proteins and genes encoding them
WO2000078961A1 (en) * 1999-06-23 2000-12-28 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1068312A2 (en) * 1998-04-09 2001-01-17 Genset 5' ests and encoded human proteins
NZ531664A (en) * 1998-09-01 2005-07-29 Genentech Inc Pro1317 polypeptides and sequences thereof with homology to the semaphorin B glycoprotein family
WO2000029579A1 (en) * 1998-11-13 2000-05-25 Zymogenetics, Inc. Mammalian chondromodulin-like protein
EP1144614A4 (en) * 1999-01-19 2003-08-06 Human Genome Sciences Inc 33 human secreted proteins
EP1208202A2 (en) * 1999-09-01 2002-05-29 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU784054B2 (en) * 1999-09-29 2006-01-19 Teijin Limited Novel polypeptides and genes encoding the same
JP2001299363A (en) * 1999-12-27 2001-10-30 Takeda Chem Ind Ltd New polypeptide and dna encoding the same
WO2001048203A1 (en) * 1999-12-27 2001-07-05 Takeda Chemical Industries, Ltd. Novel protein and dna thereof

Also Published As

Publication number Publication date
AU3647701A (en) 2001-07-31
JP2003520590A (en) 2003-07-08
WO2001053344A2 (en) 2001-07-26
MXPA02007119A (en) 2003-04-14
CA2398695A1 (en) 2001-07-26
EP1261639A2 (en) 2002-12-04
WO2001053344A3 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
BR9814404A (en) "expression cloning in filamentous fungi"
DK1015587T3 (en) DcR3 polypeptide, a TNFR homolog
BRPI0416744A (en) improved protein expression systems
AR055191A1 (en) GENERATION AND CHARACTERIZATION OF THERAPEUTIC ANTIBODIES DERIVED FROM HUCAL- GOLD FULLY HUMAN SPECIFIC FOR THE HUMAN CD38
IL175021A0 (en) Chromatin insulator, its preparation and use in protein expression
BG103091A (en) Shortened soluble receptors of type i & ii of the tumour necrotizing factor
WO2001064835A8 (en) Novel nucleic acids and polypeptides
ATE414775T1 (en) POLYPEPTIDES WITH PROLYLDIPEPTIDYLAMINOPEPTIDASE ACTIVITY AND NUCLEIC ACIDS CODING THEREFOR
NO20032286L (en) Use of ClyA hemolysin for protein excretion
CL2019003405A1 (en) Isolated tumor associated peptide (tumap); nucleic acid; expression vector; recombinant host cell comprising the peptide; method of producing the peptide; use to prepare a rare useful drug to treat cancer; pharmaceutical kit. (divisional request 201702407)
ATE473238T1 (en) TUBERCULOSIS VACCINE WITH IMPROVED EFFICIENCY
ATE384787T1 (en) TRIPEPTIDYL AMINOPEPTIDASE
DE69837475D1 (en) POLYPEPTIDES WITH AMINOOPEPTIDASE ACTIVITY AND NUCLEIC ACIDS THEREFOR
DE69938240D1 (en) NEW G-PROTEIN-COUPLED RECEPTOR
DK1157100T3 (en) Oxaloacetate hydrolase-defective fungal host cells
DE60118359D1 (en) HUMAN PELLINO POLYPEPTIDE
ES2136583T1 (en) PROCEDURES AND COMPOSITIONS FOR THE SUPPLY AND EXPRESSION OF INTERFERON ALPHA NUCLEIC ACIDS.
BR0313135A (en) T cell epitopes in erythropoietin
AR027238A1 (en) CONDROMODULIN-I-RELATED PEPTIDE
SG165168A1 (en) New adenoviruses, nucleic acids coding therefor and their use
EP1480998A4 (en) Intermediates and methods for making heptapeptide oxytocin analogues
ATE471382T1 (en) VAC-BAC SHUTTLEVECTOR SYSTEM
PE20190967A1 (en) MODIFIED ISOLATED STREPTOMYCES FUNGICIDICUS AND ITS USE
MX2022013737A (en) Novel protein, and therapeutic and cosmetic uses thereof.
AR040521A1 (en) SYNTHETIC GEN CODIFYING THE STIMULATING FACTOR OF HUMAN GRANULOCIT COLONIES FOR EXPRESSION E. COLI

Legal Events

Date Code Title Description
FB Suspension of granting procedure